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After specific activation by antigen, B cells differentiate into antibody-secreting 
plasma cells under the influence of a variety of factors (iymphokines) secreted by 
inducer/helper T  cells  (1-3).  It  is  not  yet clear  how  many lymphokines are 
specific for B cells but one,  IL-2, has been shown to bind to both activated B 
cells and activated T  cells (4-7), suggesting that at least one lymphokine reacts 
with both cell types. The role of IL-2 in B cell differentiation is undefined, but 
it is well established that it plays an essential role in the clonal expansion of T 
cells (6). 
The multiplicity of lymphokines raises the question: is there functional spe- 
cialization among inducer/helper T  cells such that some provide differentiation 
factors reactive solely with B cells while others produce IL-2? Such heterogeneity 
would, in principle, provide a  means of independently regulating the humoral 
and cellular components of the  immune response,  and would therefore have 
important theoretical, and possibly practical, implications. 
In an earlier publication (8),  Woolett et al. showed that an mAb, MRC OX- 
22,  raised against  PHA-induced rat  T  cell  blasts,  and reactive with the  high 
molecular weight forms of the leukocyte-common  antigen, revealed a phenotypic 
heterogeneity among rat CD4  ÷ T  cells,  in that about two-thirds of these cells 
reacted with the antibody, and one-third did not. It was further shown (9) that 
the MRC OX-22-  subset provided help for B cells  in vivo, whereas the MRC 
OX-22 + population mediated graft-vs.-host reactivity and lethal GVHD. These 
experiments, although indicating that CD4  + T  cells in the rat were functionally 
heterogeneous, did not provide data as to the ability of the two T  cell subsets to 
secrete the iymphokine IL-2. 
Herein,  using in  vitro assays for alloreactivity, IL-2 production, and B  cell 
help, we extend the in vivo data by showing that the MRC OX-22- population, 
while synthesizing little or no IL-2, was very effective at providing help for in 
vitro antibody production.  In  contrast, the  MRC OX-22 + subset produced as 
much  IL-2  as  unfractionated CD4  +  T  cells,  but  was  relatively ineffective at 
inducing B cells to differentiate into antibody-secreting cells. 
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Materials and  Methods 
Animals.  All rats were from the specific pathogen-free unit of the Medical Research 
Council (MRC) Cellular Immunology Unit. The strains used were PVG.RT1 c, PVG-RT1 u 
(AO), and DA.RTI ~, but for brevity these will be referred to as HO, HO.B2, and DA, 
respectively. Donors of cells used as stimulators in the mixed leukocyte cultures (MLC) ~ 
were Fz hybrids of these strains. Rats were primed to DNP-bovine gamma globulin (DNP- 
BGG) by injecting 1 mg of alum-precipitated antigen i.p. together with 109 killed Bordetella 
pertussis.  Rats were used as thoracic duct lymphocyte (TDL) donors at least 4  wk after 
priming. 
Cells.  TDL were obtained by cannulation of the duct (! 0), and were collected at 4°C 
overnight into flasks containing Dulbecco's A +  B medium (DAB) and 20 U/ml heparin. 
Spleens  were  removed  from  rats  killed  by ether  overdose,  and  the  splenocytes were 
isolated by pressing fragments of spleen through a stainless steel mesh into ice-cold DAB 
containing 0.2% BSA. 
Isolation  of Subsets of Lymphocytes.  Subpopulations of TDL were prepared by negative 
selection by the rosetting technique described by Parish and Hayward (1 I) and  Mason 
(12).  Briefly, TDL were incubated with mouse mAb that labelled the subpopulation(s) to 
be removed, then washed and mixed with SRBC coated with immunoabsorbant-purified 
rabbit anti-mouse Ig. The rosettes so formed were removed by differential centrifugation, 
and the nonrosetting cells were harvested from the supernatant.  Cell fractionation was 
also carried out by means of a  FACS II (Becton Dickinson Immunocytometry Systems, 
Sunnyvale, CA) using mouse mAb against rat cell membrane antigens to label the cells. 
Antibody-binding  cells  were  revealed  by  a  second  incubation  step  with  fluorescein- 
conjugated  rabbit  F(ab')2 anti-mouse Ig (RAM-FITC) (9).  For all fractionation proce- 
dures, cell purities were assessed by FACS analysis. 
Monoclonal  Antibodies.  The  derivation  of the  mouse  mAb  used  in  this  work,  viz: 
W3/25 (anti-CD4) (13), MRC OX-8 (anti-CDS) (13), MRC OX-12 (anti-rat K chain) (14), 
M RC OX-6 (anti-rat I-A) (15), M RC OX-19 (13), W3/I 3 (pan T) (16), and M RC OX-22 
(9) have all been described in the references given. 
Mixed  Leukocyte  Cultures.  MLC  were  performed  as  described  (17)  using  TDL  or 
subpopulations  thereof as  responders  and  F~  hybrid  splenocytes  as  stimulators.  The 
splenocytes were irradiated with 1,900 rad ~TCs 3, irradiation before culture. 
Con A Responses.  T  cell subpopulations isolated from TDL were incubated, in various 
doses,  in  96-well  round-bottomed  tissue  culture  plates  with  10  ug/ml  Con  A,  in  the 
presence or absence of accessory cells. After 48 h in culture, [~H]thymidine was added to 
the wells, and incorporation of the label was determined after a further 18 b of culture. 
Cell doses and purities are given in Fig. 4. 
Assays for  IL-2.  The  IL-2  content  of tissue  culture  supernatants  was  determined 
according to Cantrell et al. (18) by measuring the ability of these supernatants to induce 
[3H]thymidine incorporation in Con A-activated blasts. 
In Vitro Antibody  Synthesis.  Fixed numbers of DNP-primed B cells and non-B, non-T 
accessory cells were plated out in 96-well round-bottomed tissue culture plates, and graded 
doses of DNP-BGG-primed T  cells,  or subpopulations of these, were added to the wells 
together with 10 ng/ml DNP-BGG. The accessory cells were prepared by incubating TDL 
with a mixture of MRC OX-8, MRC OX-12, and W3/13 mAb, and removing the labelled 
cells by rosetting with rabbit anti-mouse Ig-coated SRBC. After 6 d in culture, superna- 
tants were assayed for anti-DNP antibody using a solid-phase RIA (9). The number of B 
cells, accessory cells, and T  cells used are given in Figs. 6 and 7. 
Results 
MRC 0X-22  mAb  Divides Rat  CD4 + T  Cells Into  Negative  and  Weakly Positive 
Subsets.  Fig.  1 a  shows that  labelling of rat TDL  with  MRC  OX-22  antibody, 
l Abbreviations used in this paper:  BGG,  bovine gammaglobulin; DAB, Dulbecco's A + B medium; 
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FIGURE  1.  MRC OX-22 mAb subdivides the CD4  ÷ T  cell subset. TDL, collected overnight 
at 4°C, were divided into two fractions. One fraction was incubated with MRC OX-22 mAb 
washed twice, and  incubated with  RAM-F1TC.  The  other  fraction  was  incubated with a 
mixture of MRC OX-12  (anti-rat K chain) (14),  and MRC OX-8 (anti-rat CDS) (13)  mAb. 
After washing, these cells were mixed with RAM-coated SRBC, and the rosette-forming cells 
were (11)  removed by differential centrifugation (12).  The recovered non-rosette-forming 
cells, which were >96% W3/25  + (CD4+), were then labelled with MRC OX-22 mAb followed 
by RAM-F1TC. All incubations were for 1 h at 4°C. After labelling, cells were examined on 
the FACS. Both scales are linear. 
followed, after washing, by RAM-FITC, produced a trimodal fluorescence profile 
on the FACS. After removal of B cells and MRC OX-8  + (CD8  +) ceils, a bimodal 
profile  was  obtained  (Fig.  1 b),  revealing  that  the  W3/25 + (CD4  +)  cells  were 
present in the negative and weakly positive components of the Fig.  1 a profile. 
Proliferation  and IL-2 Production in MLC.  The data in  Fig.  2  show that  the 
phenotype of the principal  responding  cell in the  semiallogeneic  MLC is  OX- 
22  +. The level of proliferation  found in the cultures containing the MRC OX- 
22 + subset was equal  to  that  of unfractionated  TDL,  an  equivalent  response 
from the MRC OX-22- population requiring a fourfold greater number of cells. 
The  use  of semiallogeneic  stimulators  meant  that  effects explainable  by back 
stimulation (17) were avoided. Since there is a requirement for CD4 + cells in this 
assay (17), it is clear that the primarily alloreactive cell in the rat MLC is CD4 + 
MRC OX-22 +. A similar result was obtained after removing the B cells and CD8  ÷ 
cells by rosetting  before sorting on the  FACS,  and  using the  recovered MRC 
OX-22 + and  MRC OX-22- cells as responders in equal cell numbers (data not 
shown). Fig. 3 illustrates the ability of CD4 + MRC OX-22 ÷ cells to produce IL- 
2  in  amounts  similar  to  those  synthesized  by unfractionated  CD4  ÷ cells.  The 
MRC OX-22- fraction, by comparison, generated far lower levels of the growth 
factor. 
Proliferation  and IL-2 Production after Lectin Stimulation.  Fig. 4 shows that the 
majority of the proliferation observed in response to Con A by CD4  + cells resides 
in the MRC OX-22 ÷ subpopulation and is accessory cell dependent. The data in ARTHUR  AND  MASON  777 
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F~C,  URE  2.  The MRC OX-22 phenotype of the responding cell in the semiallogeneic MLC. 
MRC OX-22  + and MRC 0X-22- subpopulations of HO TDL, isolated directly by sorting on 
the  FACS, and unfractionated TDL  were cultured at varying concentrations with 5  x  105 
irradiated (HO x  HO.B2)Fj splenocytes as stimulators. The numbers of responders used were 
adjusted such that each population tested contained approximately the same number of CD4  + 
T  cells. For example, at the highest concentration  tested (1.6 ×  105 responder T  cells/well), 
3.72 x  105 MRC 0X-22 ÷ cells, 2.08 x  105 MRC 0X-22- cells, and 3.2 x  105 unfractionated 
TDL were cultured. Control cultures of responders or stimulators alone incorporated no more 
than 1,300 cpm. Data are means and ranges of triplicate determinations. Purities were >99% 
for both. Cultures were carried out in 0.2-ml volumes of RPMI  1640 containing 5% DA rat 
serum  in  96-well round-bottomed tissue culture plates with 5  X  105 irradiated (1,900  fads 
~7Cs  3' irradiation) stimulators.  After 72  h  incubation at 37°C,  5% CO2,  0.5 #Ci  of [SH]- 
thymidine were added, and 18 h later, the wells were assayed for incorporation of label. 
Fig. 5 show that most of the IL-2 produced by such polyclonal activation of the 
CD4 + subset is from the MRC OX-22 ÷ cells, with an equal number of MRC OX- 
22-  cells  at  the  highest  responder  dose  measured  producing  approximately 
fourfold less growth factor, as gauged by blast cell proliferation. 
T Help  for Antihapten Antibody Responses.  It has been shown that CD4  ÷ T  cells 
in the rat provide helper activity for B cells in a primary in vitro system generating 
antibody against SRBC (19),  whereas CD8 + cells act instead to suppress such a 
response.  Similar  results  have  recently  been  obtained  using  an  assay  system 
designed to  measure a  secondary antihapten  response  to  DNP by DNP-BGG- 
primed B cells (data not shown). The CD4  + population, from DNP-BGG-primed 
donors,  was then  further  fractionated  on  the  FACS into  its constituent  MRC 
OX-22 + and MRC OX-22- subsets to determine whether a difference could be 
discerned  in  their  ability to help a  secondary antibody response  in  vitro.  The 
data in  Fig. 6  show that a  marked heterogeneity in helper capacity was indeed 
found,  with  MRC  OX-22-  cells  ~16  times  as  potent  on  a  cell  for  cell  basis 778  INTERLEUKIN  2  PRODUCTION  AND  B  CELL  HELP 
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FIGURE 3.  The  MRC  OX-22  phenotype of IL-2-producing cells in  semiallogeneic  MLC. 
CD4  + T  cells were obtained from HO TDL by removing MRC OX-8 + (CD8 ÷) and MRC OK- 
12  + cells by rosette depletion as described in the caption for Fig.  I. Recovered cells were then 
kept on ice at 4°C or labeled with MRC OX-22 and sorted on the FACS into positive and 
negative  fractions.  After  washing  twice,  all  populations  were  incubated  at  37°C  at  four 
different cell doses, with 5  x  10  ~ irradiated FI spleen cells. After 48 h,  150  ~1 aliquots of 
supernatant were removed from each well and tested for IL-2 activity. Data are means and 
ranges of quadruplicate determinations. Purities of sorted cells were >99% in both cases. To 
assay the IL-2,  Con  A-stimulated cells were incubated at 37°C  for  3  d  at  106 cells/ml, in 
RPM1 or DMEM supplemented with 5% DA rat serum. Blasts were then harvested, washed 
several times in.medium containing a-methylmannoside at 20 mg/ml, and cultured in 0.2-ml 
volumes at 4  ×  104 cells/well. Appropriate cultures contained 50% (vol/vol) of conditioned 
medium  to be assayed for IL-2.  After  18 h, assessment of proliferation was made by [~H]- 
thymidine incorporation with a 6-h pulse of 0.5 gCi/well (17). 
compared with MRC OX-22" cells in providing help for B cells to produce anti- 
DNP antibody. Similarly, when B cells and accessory cells plus DNP-BGG were 
supplemented with  fixed numbers  of MRC  OX-22 + and  MRC  OX-22-  cells, 
supernatants from the cultures containing the MRC OX-22-  subsets produced 
>10 times as much anti-DNP antibody as those with MRC OX-22 + cells (data 
not shown). 
IL-2 Synthesis in Antibody-producing Cultures.  To study the association between 
IL-2 synthesis and the generation of B cell help, a series of cultures were set up 
with DNP-BGG-primed B cells, accessory cells, and MRC OX-22 + or MRC OX- 
22- DNP-BGG-primed CD4 + T cells. To these cultures were added either specific 
antigen, Con  A,  or  medium alone.  Cultures were  then assayed for anti-DNP 
antibody on  day  6  of culture,  or  for  IL-2  on  day  2  of culture with  Con  A 
stimulation, and on day 3  for the specific antigen or no antigen wells.  These 
intervals were chosen on the basis of initial experiments that showed that IL-2 
production and antibody production peaked on the days indicated. 
The results in Fig. 7 confirm those illustrated in Fig. 6, in that the MRC OX- 
22- subset of CD4 + T  cells was much more effective than the MRC OX-22 ÷ one 
at providing B cell help for anti-DNP antibody responses when specific antigen 
was used. The figure also shows that some antibody was produced when Con A, ARTHUR  AND  MASON  779 
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FIGURE 4.  Proliferative response of MRC  OX-22  + and  MRC OX-22- subsets to Con  A. 
CD4 + T  cells were isolated from HO TDL and separated into MRC OX-22  + and MRC OX- 
22-  fractions, as described in  Fig.  3,  except that in  the preparation of the CD4 + cells by 
rosette-depletion, MRC OX-6 (anti-Ia) (15) antibody was added to the mixture of MRC OX-8 
and MRC OX-12 antibodies to ensure that any la  + cells present were also removed in  the 
rosetting process. The  MRC OX-22  + and  MRC  OX-22- cells were  then aliquoted in  the 
presence of Con A at l 0/~g/ml in DMEM with 5% rat serum, with or without addition c)f 5.7 
x  104 irradiated non-B, non-T accessory cells per well. Proliferation was assessed with an 18- 
h [SH]thymidine pulse after 48  h  incubation. Data are means and ranges of triplicate deter- 
minations, and three separate repetitions of this experiment produced similar results. All plots 
have background counts with medium alone subtracted. Rosette depletion purities were 97.2% 
and 93.6% for CD4  + (strictly MRC OX-6-, MRC OX-8-, MRC OX-I 2  ~ cells) and accessory 
cells (MRC OX-8-, MRC OX-12-, W3/I 3-), respectively. Purities for the sorted populations 
were: MRC OX-22  +, 97.4%; MRC OX-22-, 99.7%. Closed symbols, with accessory cells added; 
open symbols, without accessory cells added. 
rather than specific antigen, was added to the cell mixtures in culture. However, 
as with  the  wells containing  specific antigen,  most antibody was found in  the 
wells containing MRC OX-22- cells. No antibody was produced in wells contain- 
ing B cells, accessory cells, and T  cells but no antigen or Con A. The IL-2 assay 
data are  shown in  Fig. 8, and illustrate  two points.  When specific antigen  was 
added to the wells, little IL-2 was measured even in cultures that produced the 
most antibody; indeed, IL-2 levels were little higher than  those detected when 
no antigen was added. In contrast, in cultures with Con A, IL-2 production was 
high  if the  wells contained  unfractionated  CD4  + T  cells or the  MRC OX-22 + 
subset of tbese cells,  but as expected,  the  MRC  OX-22-  cells produced  little 
lymphokine. 
Taking the data in Figs.  7 and  8  together,  it is clear that  there is a  marked 
dissociation between IL-2 synthesis and antibody production, even when the two 
are assayed from  the  same well.  The  results are,  however, entirely consistent 
with those presented  in  Figs.  5 and  6,  which also showed that,  in independent 
experiments, IL-2 secretion and B cell help were largely mediated by MRC OX- 
22 + and MRC OX-22- T  cells, respectively. 780  INTERLEUK1N  2  PRODUCTION  AND  B  CELL  HELP 
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FW,  URE  5.  IL-2 production by CD4 + MRC OX-22 + and CD4 + MRC OX-22- cells after Con 
A  stimulation. After removal of B cells, CD8 + T  cells, and la  + cells by rosette depletion, the 
residual CD4 + ceils were sorted on the FACS into MRC OX-22- and MRC OX-22 + subsets. 
Sorted populations were stimulated with 10 #g/ml Con A with or without 4.3 ×  104 irradiated 
non-B, non-T accessory cells, isolated from TDL, for 24 h before supernatants were harvested 
and tested for growth factor activity. All data are means and ranges of triplicate determinations, 
and  have background counts with medium alone subtracted. Two further assays produced 
similar results. CD4  + and accessory cells were 99.3% and 90.8% pure respectively, and postsort 
purities for MRC OX-22 + and MRC OX-22- cells were 98% and 99%, respectively. Closed 
symbols, with accessory cells added; open symbols, without accessory cells added. 
Discussion 
Fractionation of rat CD4  + T  cells using MRC OX-22 mAb, which is known to 
recognize  the  high  molecular  weight  form  of the  leukocyte-common antigen, 
reveals striking differences in the potentials of MRC OX-22 ÷ and MRC OX-22- 
subpopulations to proliferate and to secrete IL-2 upon allogeneic or nonspecific 
stimulation,  and in their  ability to facilitate antibody secretion from primed  B 
cells during in vitro culture. 
The results show that,  within the CD4 ÷ subset, it is predominantly the MRC 
OX-22 + cells that proliferate in response to aUoantigens or T  cell mitogen, and 
that  synthesize  readily  detectable  levels  of  IL-2  in  either  of these  cases.  In 
contrast, the MRC OX-22- cells provide optimum help for secondary antihapten 
antibody responses. 
These  results  are  in  agreement  with  previous  (9)  in  vivo observations  that 
MRC OX-22 ÷ cells are responsible for alloreactivity in the popliteal lymph node 
assay, and for causation of GVHD in irradiated F~ hybrid rats. The finding that 
the helper activity for B cells resides within the CD4  + MRC OX-22- population 
also agrees with the published results (9) for in vivo anti-DNP antibody produc- 
tion.  Our data suggesting that  IL-2 synthesis and  B cell help are  mediated by 
different T  cell subsets are consistent with the observation (3) that some human 
T  cell hybridomas are able to secrete B cell differentiation factor but not IL-2, 
and with the discovery of an immunodeficient individual  whose T  cells secrete ARTHUR  AND  MASON  781 
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FIGURE (5.  The T  helper cell for a  secondary in vitro antihapten response is CD4  +,  MRC 
OX-22-,  TDL  from rats primed with 0.5 mg DNPs6-BGG -4  wk earlier were prepared by 
rosette depletion into CD4 ÷ cells (MRC OX-6-, MRC OX-8-, MRC OX-12-), B cells (W3/25-, 
MRC  OX-8-) and accessory cells (MRC  OX-8-,  MRC  OX-12-,  W3/13-)  (purities  98.1%, 
98.5%, and 86.6% respectively); CD4 ÷ cells were then sorted into MRC OX-22  + (purity, 98%) 
and MRC OX-22- (purity, 99.8%) fractions. Triplicate cultures containing 10 ng/ml DNPs~- 
BGG, 3.9 x  105 B cells, and 1.6 x  104 accessory cells/well, in a total volume of 300 tA DMEM 
plus  10%  FCS  were  then  incubated with  putative helper populations,  including unprimed 
TDL, at T  cell doses ranging from 2.5 x  l& cells]well to 8 x  l0  s cells/well for 6 d, when 200 
#l supernatant was harvested from each well. This supernatant was then tested for the presence 
of anti-DNP antibody in a  solid-phase RIA (9). All data are the means of triplicate determi- 
nations. Control supernatant from cultures containing no T  cells gave 849 cpm bound.  A 
further experiment gave  the same  result.  Closed  symbols,  ceils obtained from  DNP-BGG- 
primed rats; open symbols, cells obtained from unprimed rats. 
B  cell  differentiation  factor and  B  cell  growth  factor but not  IL-2  (20).  Also, 
Lamb and  coworkers (21)  were able to  dissociate  IL-2  synthesis  from  helper 
activity upon analysis of a panel of influenza virus-immune human T  cell clones; 
this was found to correlate with  phenotypic heterogeneity,  Leu-8 (22) and  9.3 
(23) mAb staining being higher in the IL-2-producing clone. 
In the assays of T  cell function used to examine the roles of the MRC OX-22  + 
and MRC OX-22- subsets of CD4  + T  cells, it may be noted that the MRC OX- 
22- cells were active only in the assay (B cell help) that used antigen-primed cells, 
whereas the MRC OX-22 + cells were active in assays in which unprimed T  cells 
were employed (MLC and  mitogen  responses).  This  use of antigen-primed  T 
cells in some assays but not others  raised  the possibility that  the expression or 
nonexpression of the MRC OX-22 antigen reflected a change in phenotype after 
priming rather  than  the existence of two independent subsets of CD4  + T  cells. 
This suggestion  is supported by the finding that T  cell blasts, recovered from 
the rat MLC, are MRC OX-22- (J. R. Green, personal communication), although, 
as  our  data  show,  the  T  cells  that  respond  most  vigorously  in  this  assay are 
initially  MRC OX-22  + (whether  the MRC OX-22 antigen  is reexpressed when 
the  T  blasts revert  to their  resting  state  is not yet known).  However, arguing 
against the hypothesis that the heterogeneity of MRC OX-22 antigen expression 782  INTERLEUKIN 2  PRODUCTION  AND  B CELL HELP 
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FIGURE 7.  Antihapten antibody production by primed B cells in response to specific antigen, 
mitogen or no antigen.  The ability of CD4 + T  cells and MRC OX-22  + and MRC OX-22- 
fractions thereof to provide B cell help for anti-DNP antibody responses was assayed as in Fig. 
6, with the following additional  steps. Some wells were set up without the addition of specific 
antigen,  and in some, Con A, at 10/~g/ml,  was used in its place. After 36 h (Con A) or 72 h 
(spec~c antigen or no antigen),  200  /~1 of supernatant  was removed and assayed for IL-2 
content. 200 ~1 fresh  medium was added back to each well, the cultures  were reincuhated, 
and assayed for anti-DN P antibody on day 6. Independent experiments (not shown) confirmed 
that the removal of the 200 IA culture supernatant at 36 or 72 h did not affect the anti-DNP 
antibody titer measured on day 6, and that IL-2 titers peaked on the days chosen for assay. 
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amongst CD4 + T  cells reflects their  immune status rather than their function is 
the observation  that the  MRC OX-22-  subset,  in contrast to the MRC  OX-22 + 
one, responds poorly to the T  cell mitogen Con A. Although the mode of action 
of  this  nonspecific  mitogen  is  not  understood,  there  is  no  evidence  that  it 
stimulates  only unprimed  cells.  Furthermore,  when  the  effect of adult  thymec- 
tomy on the ratio of CD4 +, OX-22-]CD4 +, OX-22 + cells was determined,  it was 
found to decrease  (Table  I). This  result  is  opposite  to that  predicted  from the 
assumption that the MRC OX-22 + subset of CD4  + T  cells gives rise to long-lived 
memory cells that are MRC OX-22-. 
A  number of mAb have been described (22-26) that identify subsets of human 
CD4 ÷  T  cells.  Although  functional  studies  using  these  mAb  have  not  been  as 
comprehensive as those described for MRC OX-22, there are similarities between 
the data obtained in the two species.  In particular,  Morimoto and his coworkers 
(25, 26) have described two antibodies, 4B4 and 2H4, that label two independent 
subsets  of CD4 + T  cells.  The  4B4  ÷,  2H4-  subset  resembles  the  MRC  OX-22- 
subset  of  rat  CD4 +  T  cells  in  proliferating  poorly  to  Con  A  but  providing 
effective  B  cell  help  in  PWM-induced  Ig  synthesis,  whereas  the  4B4-,  2H4 + 
subset behaves in a  reciprocal fashion in these two assays, and thus functions like 
MRC OX-22  ÷, CD4 ÷ cells. The  fact that the human data obtained with PWM, a ARTHUR  AND  MASON  783 
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FIGURE 8.  Dissociation between anti-DNP antibody production and  IL-2  secretion. The 
supernatants removed at 36 and 72 h from the culture wells described in Fig. 7 were assayed 
for IL-2 content as described for Fig. 3. 
TABLE  I 
Antibody Labelling of TOL from Normal and Thymectomized Rats 
Labeled cells (%) 
Normal rats at various 
Antibody  Specificity  intervals (wk) 
Thymectomized rats 
at intervals (wk) after 
thymectomy 
5  8  13  5  8  13 
OX-6  l-A  48.8  49.9  58.4  66.4  66.3  69.2 
OX-8  CD8  7.7  9.7  9.4  5.0  5.5  6.3 
OX-12  Rat Ig  50.8  48.7  58.5  65.1  66.1  68.4 
OX-19  CD5  44.8  55.1  43.7  32.5  34.3  29.0 
OX-21  Negative control  0.4  0.4  0.8  0.4  0.2  0.6 
OX-22  L-CA  81.7  86.6  88.3  93.7  93.1  92.1 
W3/25  CD4  ÷  40.6  47.5  31.3  30.9  31.1  27.4 
OX-22 +  W3/25  L-CA +  CD4  ÷  95.8  98.0  97.4  98.0  98.6  96.6 
Data are means of duplicate determinations. 
MRC OX-21 reacts with human C3b inactivator and is used here as a negative control. 
nonspecific inducer of Ig  synthesis,  are  in  accordance with  the results  using 
specific antigen in the rat supports the conclusion that MRC OX-22-, CD4 ÷ cells 
in the rat are specialized for B cell help rather than merely being memory cells. 
There is presumably some functional significance in the heterogeneity of CD4 + 
T  cells revealed herein. The fact that high-level IL-2 production can be achieved 
in  the absence of significant levels of B  cell helper activity suggests that  cell- 
mediated immune responses may be regulated independently of antibody-medi- 
ated ones. Similarly, as potent B cell help can develop with little concomitant IL- 
2 production, antibody synthesis may proceed without the development of cell- 
mediated immunity. It is well established (27) that cytotoxic T  cells (the devel- 
opment of which is almost certainly IL-2  dependent) can be generated against 784  INTERLEUKIN 2  PRODUCTION AND  B CELL HELP 
minor transplantation antigens in the complete absence of a humoral response, 
and it is evident that many antibody responses are evoked, those against soluble 
antigens, for example, for which a cell-mediated response does not occur. The 
existence of  different T cell subsets providing help for humoral and cell-mediated 
responses provides the possibility of regulating these two arms of the immune 
response independently. 
Summary 
An mAb MRC OX-22,  reactive with the high molecular weight forms of the 
rat  leukocyte-common antigen,  has revealed a  heterogeneity among CD4  + T 
cells in this species. Approximately two-thirds are CD4  ÷, OX-22 ÷, and one-third 
are CD4  +,  OX-22-.  This phenotypic heterogeneity was found to be associated 
with a functional one. CD4  +, OX-22 ÷ cells proliferated well in mixed leukocyte 
culture, responded to the T cell mitogen Con A, and produced IL-2 on activation. 
In contrast, the CD4  +, OX-22- cells performed poorly in these assays, but unlike 
CD4  ÷, OX-22 + cells,  did provide effective help for B cells.  By sampling super- 
natants from cultures containing primed B cells and either of the two CD4  + T 
cell subsets, it was shown that, when specific antigen was included in the cultures, 
those  containing  the  OX-22-  subset  of CD4 +  cells  produced  high  levels  of 
antibody and some IL-2, whereas those containing the OX-22 ÷ cells produced 
neither.  In contrast, when specific antigen was replaced by Con A,  the B cell 
cultures supplemented with CD4  +, OX-22 + cells synthesized much higher levels 
of IL-2 than those containing CD4  +, OX-22-  cells,  but only the latter cultures 
produced detectable levels of antibody. 
The data show that inducer/helper T  cells  comprise two functional subsets: 
one that, on appropriate stimulation, synthesizes high levels  of IL-2, and may 
therefore be presumed to play an important role in cell-mediated immunity, and 
another that plays an  essential role  in  humoral responses to soluble antigens. 
The significance of this functional heterogeneity, with regard to the possible 
independent regulation of cellular and humoral responses, is briefly considered. 
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